Literature DB >> 8077674

Activation of human monocytes by the pineal hormone melatonin.

K M Morrey1, J A McLachlan, C D Serkin, O Bakouche.   

Abstract

To determine the effects of the pineal hormone melatonin on human monocytes, human monocytes were activated by different concentrations of melatonin. Above the activation threshold of 5 x 10(-11) M, melatonin was able to induce the cytotoxicity of human monocytes, the secretion of IL-1, and the production of reactive oxygen intermediates. Melatonin and LPS seemed to have a synergistic effect on human monocyte activation. Indeed, below their respective monocyte activation threshold (5 x 10(-11) M and 0.625 ng/ml), melatonin (10(-12) M) in association with LPS (0.2 ng/ml) was able to induce cytotoxicity, IL-1 secretion, and reactive oxygen intermediates production. Melatonin alone at 10(-12) M or LPS alone at 0.2 ng/ml did not activate monocytes. Furthermore, melatonin was able to prime the monocytes for a subsequent activation by LPS. When monocytes were activated by LPS (0.25 ng/ml) at the time that they were plated and then activated by melatonin (10(-12) M) 8 h later, no IL-1 secretion and no cytotoxicity were detected. However, when the cells were first activated by melatonin (10(-12) M), and then 8 h later by LPS (0.25 ng/ml), IL-1 secretion and monocyte cytotoxicity were observed. Above its monocyte activation threshold, melatonin induces both cell-associated IL-1 alpha and IL-1 beta activities. Below this activation threshold, i.e., at 10(-12) M, melatonin does not induce the cell-associated IL-1 alpha and IL-1 beta activities, but does induce the mRNA for both IL-1 (alpha and beta). It seems that melatonin activates monocytes through protein kinase C. These data suggest that melatonin activates monocytes and induces their cytotoxic properties, along with the IL-1 secretion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077674

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Circadian rhythms in RA.

Authors:  M Cutolo; B Seriolo; C Craviotto; C Pizzorni; A Sulli
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

Review 2.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 3.  The melatonin-cytokine connection in rheumatoid arthritis.

Authors:  M Cutolo; G J M Maestroni
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

4.  Effect of the preventive-therapeutic administration of melatonin on mammary tumour-bearing animals.

Authors:  M C Saez; C Barriga; J J Garcia; A B Rodríguez; E Ortega
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

5.  The putative melatonin receptor antagonist GR128107 is a partial agonist on Xenopus laevis melanophores.

Authors:  M T Teh; D Sugden
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Immunomodulatory effect of melatonin in SK-LU-1 human lung adenocarcinoma cells co-cultured with peripheral blood mononuclear cells.

Authors:  P Plaimee; M Khamphio; N Weerapreeyakul; S Barusrux; N P Johns
Journal:  Cell Prolif       Date:  2014-07-23       Impact factor: 6.831

7.  Intervention in the aging immune system: Influence of dietary restriction, dehydroepiandrosterone, melatonin, and exercise.

Authors:  M A Pahlavani
Journal:  Age (Omaha)       Date:  1998-10

8.  Dose-dependent dual effect of melatonin on ototoxicity induced by amikacin in adult rats.

Authors:  Tamer Erdem; Orhan Ozturan; Mustafa Iraz; Murat Cem Miman; Ercument Olmez
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-28       Impact factor: 2.503

9.  Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Anaís Nery; Ernesto Bonilla; Luz Marina Espina; Leonor Chacin-Bonilla; Florencio Añez; Mery Maldonado; Eddy Meleán
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

Review 10.  Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

Authors:  R Jockers; P Maurice; J A Boutin; P Delagrange
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.